BANT and MEDDIC are sales qualification frameworks that help teams investigate whether an opportunity is real and how a buying decision may happen. They organize discovery questions; neither framework predicts a win by itself. The best choice depends on deal complexity, sales cycle, available evidence, and how the team uses the answers.
What each framework covers
BANT stands for Budget, Authority, Need, and Timing. It is compact and can help structure an early conversation around resources, decision access, the problem, and timing. MEDDIC stands for Metrics, Economic Buyer, Decision Criteria, Decision Process, Identify Pain, and Champion. It asks for more detail about measurable outcomes, approval, evaluation, pain, and internal advocacy.
Choose for the sales motion
A shorter or transactional motion may need a lightweight set of questions, while a complex enterprise purchase can involve multiple stakeholders, formal evaluation, and implementation risk. MEDDIC may help teams capture those details, but its added fields create overhead if sellers cannot validate the information or act on it. BANT can be too simplistic when authority and budget emerge late.
- Define what counts as evidence for each answer, not just a filled-in field.
- Allow unknown or unconfirmed rather than encouraging guesses.
- Keep the customer’s language and source of information in the CRM.
- Review whether framework data helps forecasting, coaching, or next-step planning.
Avoid framework theater
Do not reject an opportunity because one field is unknown early in discovery. Do not label a contact as a champion merely because they respond. Qualification should reflect current evidence and be updated as the buyer shares more. MEDDPICC adds Paper Process and Competition to MEDDIC; teams should adopt it only when those dimensions improve their process.
How the questions differ in a deal
A buyer may have a clear need and near-term timing under BANT, while budget and final authority are still unknown. MEDDIC prompts the seller to learn the measurable outcome, decision criteria, approval process, and who can advocate internally. That additional discovery can help a complex deal, but the unknowns should remain unknown until evidence supports an answer.
Pilot a small set of questions and compare how well they support decisions across segments. Keep the framework simple enough to use and specific enough to reveal risk. The goal is better discovery, not a completed checklist.
How did this article land?
Choose one reaction. You can change it anytime.